November 11, 2016
Cardiovascular disease cuts across ethnicities and demographics as the leading cause of death in the United States, explains a new white paper from the Institute for Patient Access.
November 6, 2016
Heart health has long been on the minds of Americans. About 85.6 million people in this country are living with…
November 3, 2016
More than a year after a breakthrough drug for cystic fibrosis became available, fewer than half of patients who meet the Food and Drug Administration’s criteria can actually access the medication.
October 1, 2016
Millions of Americans and their families deal with the debilitating effects of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s.…
September 16, 2016
Along with other advocacy, education and health care organizations, the Institute for Patient Access wrote to the Institute for Clinical and Economic Review this week offering 12 suggestions on how to improve its value framework. The letter responded to ICER’s request for feedback as it prepares to update its framework for 2017.
August 30, 2016
A new analysis calls for drastic price reductions for PCSK9 inhibitors, breakthrough lipid-lowering medications. Data published in the Journal of the American Medical Association suggest that the treatments would need to be reduced to two-thirds their current price to meet analysts’ cost-effectiveness thresholds.
July 22, 2016
Patients with Alzhe.imer’s or Parkinson’s disease may have a new source of hope: cancer drugs
April 11, 2016
A physician tells a story in the Alliance for Patient Access’ oncology working group white paper about attending the funeral of one of his cancer patients.
April 1, 2016
Indiana Governor Mike Pence has signed into law a bill restricting the use of step therapy – following in the footsteps of California, Maryland, New Hampshire and other states that have tackled the issue.
August 13, 2015
For many Americans with respiratory conditions, the struggle to breathe is now exacerbated by the struggle to pay out-of-pocket expenses for the medications that alleviate their symptoms.
